A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
Clinical trial NCT04667117 · COMPLETED
Trial details
- NCT number
- NCT04667117
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-14
- Primary completion
- 2023-07-06
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.